After propensity score matching, the analytic cohort comprised 26,408 matched patients: 13,204 users and 13,204 non-users
Health concerns, no matter how minor they may seem, can severely impact your overall well-being and quality of life
For the assessment of the changes from baseline following GLP-1-based therapies in % FMD and IMT, mean differences with 95% confidence intervals (CI) were calculated between baseline samples and end-of-treatment samples for each study and then an overall effect size was generated
Orforglipron: People taking the highest approved dose of Foundayo(17.2 mg) saw an average weight loss of 11% over 72 weeks
And equally as important, how do we help them sustain progress after stopping
When you're running a sophisticated stack, the difference between guessing and knowing is the data you collect